Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm initiated by the presence of the fusion gene <i>BCR::ABL1</i>. The development of tyrosine kinase inhibitors (TKIs) highly specific to p210<i><sup>BCR</sup></i><sup>-<i>ABL1</i></...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/20/12271 |